SCHEMBL752897

SCHEMBL752897

O=C(c1ccc(F)cc1)c1ccc(Br)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
KMT2A Q03164 2/20 0.49
TSHR P16473 3/20 0.49
MAPK1 P28482 2/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 5/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 4/20 0.45
THRB P10828 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LTA4H P09960 1/20 0.44
GLA P06280 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
LMNA P02545 3/20 0.43
ALOX15 P16050 1/20 0.43
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21222589 0.86 CES2 (0.58) TSHRMAPK1NPC1ALDH1A1POLB
SCHEMBL27623978 0.80 ALDH1A1 (0.57) KMT2ATSHRALDH1A1MAPTTHRB
SCHEMBL11616860 0.75 TDP1 (0.45) KMT2ATSHRALDH1A1POLBMAPT
SCHEMBL2958453 0.74 LMNA (0.64) KMT2ATSHRMAPK1NPC1ALDH1A1
SCHEMBL11618116 0.74 PTGS2 (0.49) TSHRNPC1ALDH1A1MAPTHPGD
SCHEMBL238259 0.72 LTA4H (0.73) TSHRMAPK1NPC1ALDH1A1MAPT
SCHEMBL8572071 0.72 LTA4H (0.73) TSHRMAPK1NPC1ALDH1A1MAPT
SCHEMBL1736339 0.72 LTA4H (0.73) TSHRMAPK1NPC1ALDH1A1MAPT
SCHEMBL2892140 0.71 LMNA (0.59) KMT2ATSHRMAPK1NPC1ALDH1A1
SCHEMBL9421729 0.71 LMNA (0.59) KMT2ATSHRMAPK1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 EP disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
EP-3042894-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2016-07-13 EP disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
EP-1422218-B1 ANTIVIRAL AGENT SHIONOGI & CO (JP) 2012-03-21 EP disclosed
CN-101513402-B Antiviral agent SHIONOGI & CO 2012-03-21 CN disclosed
EP-2181985-B1 Antiviral Agent SHIONOGI & CO (JP) 2011-10-26 EP disclosed
EP-2266958-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2010-12-29 EP disclosed
EP-2181985-A1 Antiviral Agent SHIONOGI & CO., LTD. (JP) 2010-05-05 EP disclosed
CN-101513402-A Antiviral agent SHIONOGI & CO (JP) 2009-08-26 CN disclosed
CN-100491349-C Antiviral agent SHIONOGI & CO (JP) 2009-05-27 CN disclosed
CN-1558898-A Antiviral agent ��Ұ����ҩ��ʽ���� 2004-12-29 CN disclosed
US-20040229909-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2004-11-18 US disclosed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229909-A1 Antiviral agent ZC3HAV1, ZC3HAV1L, DUT MAOA 592/4885MAOB 709/4885KMT2A 516/4885
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI MAOA 729/4885MAOB 900/4885KMT2A 667/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI MAOA 729/4885MAOB 900/4885KMT2A 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.